» Authors » Malene Kaerslund Hansen

Malene Kaerslund Hansen

Explore the profile of Malene Kaerslund Hansen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 112
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thrane P, Olesen K, Thim T, Gyldenkerne C, Hansen M, Stodkilde-Jorgensen N, et al.
JACC Adv . 2025 Feb; 4(3):101614. PMID: 39983611
Background: Primary percutaneous coronary intervention (pPCI) has been the national reperfusion strategy for patients with ST-segment elevation myocardial infarction (STEMI) in Denmark since 2003. We recently reported a gradual reduction...
2.
Stodkilde-Jorgensen N, Olesen K, Gyldenkerne C, Hansen M, Nielsen R, Nielsen J, et al.
Europace . 2025 Feb; 27(2). PMID: 39960891
No abstract available.
3.
Gyldenkerne C, Olesen K, Thrane P, Hansen M, Stodkilde-Jorgensen N, Andersen M, et al.
Clin Epidemiol . 2024 Dec; 16:825-836. PMID: 39619160
The Western Denmark Heart Registry (WDHR) is a semi-national, multicenter-based clinical registry with unique potential for cardiovascular research. The registry has provided detailed prospectively registered information on patient and procedure...
4.
Thrane P, Olesen K, Thim T, Gyldenkerne C, Hansen M, Stodkilde-Jorgensen N, et al.
J Am Coll Cardiol . 2024 Jun; 83(25):2615-2625. PMID: 38897670
Background: ST-segment elevation myocardial infarction (STEMI) is associated with high early mortality. However, it remains unclear if patients surviving the early phase have long-term excess mortality. Objectives: This study aims...
5.
Hansen M, Mortensen M, Olesen K, Thrane P, Thomsen R, Maeng M
Eur J Prev Cardiol . 2024 Mar; 31(10):1238-1248. PMID: 38513361
Aims: Assessment of residual cardiovascular risk in statin-treated patients with atherosclerotic cardiovascular disease (ASCVD) is pivotal for optimizing secondary preventive therapies. This study investigates if non-high-density lipoprotein cholesterol (non-HDL-C) is...
6.
Hansen M, Mortensen M, Olesen K, Thrane P, Maeng M
Lancet Reg Health Eur . 2023 Nov; 36:100774. PMID: 38019978
Background: Identifying patients at high residual risk of atherosclerotic cardiovascular disease (ASCVD) despite statin-treatment is of paramount clinical importance. We aim to investigate if non-high-density lipoprotein cholesterol (non-HDL-C) identifies residual...
7.
Nielsen R, Anker N, Stodkilde-Jorgensen N, Thrane P, Hansen M, Pryds K, et al.
JACC Heart Fail . 2023 Aug; 11(12):1653-1663. PMID: 37632494
Background: The representation of women in heart failure studies has been inadequate, resulting in a knowledge gap regarding the prognostic impact of coronary artery disease (CAD) on all-cause mortality in...
8.
Kremke M, Hansen M, Christensen S, Tang M, Andreasen J, Jakobsen C
Eur J Cardiothorac Surg . 2015 Sep; 48(5):e102-9. PMID: 26333374
Objectives: Previous research suggests that platelet transfusion is associated with adverse events after coronary artery bypass grafting (CABG). The aim of the current analysis was to verify this hypothesis. Methods:...
9.
Nielsen D, Johnsen S, Hansen M, Jakobsen C
Anesthesiology . 2015 Jan; 122(1):211-3. PMID: 25611659
No abstract available.
10.
Hansen M, Gammelager H, Jacobsen C, Hjortdal V, Layton J, Rasmussen B, et al.
J Cardiothorac Vasc Anesth . 2015 Jan; 29(3):617-25. PMID: 25575408
Objective: To examine the impact of postoperative acute kidney injury (AKI) on the long-term risk of myocardial infarction, heart failure, stroke, and all-cause mortality after elective cardiac surgery. The authors...